|
SeqPlus sequencing methodology enables robust whole-genome sequencing, true variant detection, and novel genomic insights from archival esophageal carcinoma FFPE samples. |
| |
|
|
Stock and Other Ownership Interests - WuXi AppTec |
| |
|
Honoraria - Roche Molecular Diagnostics |
Travel, Accommodations, Expenses - Roche Molecular Diagnostics |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
|
|
Stock and Other Ownership Interests - WuXi AppTec |
| |
|
|
Stock and Other Ownership Interests - WuXi AppTec |
| |
|
|
Stock and Other Ownership Interests - WuXi AppTec |
| |
|
|
Consulting or Advisory Role - AskGene (I); Jazz Pharmaceuticals (I); Pharmacyclics (I) |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |